Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sumitomo Chemical Co ( (JP:4005) ) has shared an update.
Sumitomo Chemical has revised its financial forecast for the fiscal year ending March 31, 2025, reflecting improved performance across several segments. The company anticipates higher core operating income and net income due to increased sales in North America for its prostate cancer therapeutic agent and higher shipments of display-related materials. These adjustments indicate a positive outlook for the company’s financial health and strategic positioning in its industry.
More about Sumitomo Chemical Co
Sumitomo Chemical Co., Ltd. operates in the chemical industry, focusing on a wide range of products including pharmaceuticals, agrochemicals, and materials for ICT and mobility solutions. The company is known for its diverse portfolio and commitment to innovation in various market segments.
YTD Price Performance: 26.73%
Average Trading Volume: 180
Technical Sentiment Signal: Sell
Current Market Cap: $3.76B
See more data about 4005 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue